Loading...
InflaRx N.V.
IFRX•NASDAQ
Healthcare
Biotechnology
$2.52
$0.09(3.70%)
U.S. Market opens in 3h 44mIFRX News Today: Stay Updated with the Latest InflaRx N.V. News in Real Time
Find IFRX news now at Meyka AI. Stay informed with the latest InflaRx N.V. stocks updates, including price news, market analysis, and expert insights.
📅 2 days ago
IFRX H.C. Wainwright Maintains Buy Rating, May 12, 2026
H.C. Wainwright maintains Buy rating on IFRX, raises price target to $8 from $6. Biotech stock trades at $2.50.
Read more
📅 4 months ago
Pre-market 21 Jan 2026 AFMD Affimed N.V. (NASDAQ): $0.18 oversold bounce setup
AFMD stock trades at $0.18 pre-market; we outline an oversold bounce plan with targets and risks for NASDAQ investors
Read more